Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Legislation & Advocacy

White House Is Open to Working with Congress on Disease Research Bill

Reuters Staff  |  July 13, 2015

WASHINGTON (Reuters)—The White House said on Wednesday it was open to working with Congress on a bill that would invest in disease research and would be paid for with sales of oil from U.S. emergency reserves. The House of Representatives is considering a bipartisan bill that would increase funding for the U.S. National Institutes of…

Rheumatology Community Applauds CMS Guidance Providing ICD-10 “Safe Harbor” Period, Encourages Further Action to Ensure Responsible Transition

American College of Rheumatology  |  July 7, 2015

ATLANTA, Ga.—The American College of Rheumatology (ACR) today praised the Centers for Medicare and Medicaid Services (CMS) for issuing new guidance to provide a 12-month “safe harbor” period for physicians following the Oct. 1 implementation of the ICD-10 code set. The ACR has led legislative and grassroots efforts to responsibly address the transition to the…

Obamacare Ruling Ends Threat to U.S. Hospitals, Insurers

Caroline Humer & Bill Berkrot  |  June 27, 2015

NEW YORK (Reuters)—The U.S. hospital and health insurance industries breathed a collective sigh of relief on Thursday after the U.S. Supreme Court upheld subsidies for individuals under President Barack Obama’s signature healthcare law. Shares in hospitals surged, with several hitting all-time highs, on the expectation that patients would be able to continue paying for services….

U.S. Supreme Court Upholds Obamacare Insurance Subsidies

Lawrence Hurley  |  June 25, 2015

WASHINGTON (Reuters)—The U.S. Supreme Court preserved President Barack Obama’s signature healthcare law on Thursday, upholding crucial tax subsidies while turning aside a conservative legal challenge that could have doomed the law. “After more than 50 votes in Congress to repeal or weaken this law, after a presidential election based in part on preserving or repealing…

Most Americans Want Congress to Ensure Obamacare Subsidies

Kylie Gumpert  |  June 16, 2015

(Reuters)—A majority of Americans say Congress should make sure Obamacare subsidies to buy health insurance are available nationwide if the Supreme Court rules that the payments in at least 34 states are illegal, according to a poll released on Tuesday. The Kaiser Family Foundation poll surveyed 1,200 people from June 2 to June 9 in…

RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts

From the College  |  June 15, 2015

Dear ACR and ARHP Colleagues, In 2007, the ACR created RheumPAC as the need for strong advocacy for rheumatologists and their patients and rheumatology training and research became compelling. The Government Affairs Committee was adept at developing novel ideas and strong policies, but there was a notable gap between policy and politics. RheumPAC was started…

How Rheumatologists Can Mobilize Patients as Advocates, Activists

Christopher D. Adams, MD  |  June 15, 2015

Editor’s note: This is the first installment of a two-part series showing how a busy office-based practice can incorporate patient advocacy into its standard workflow. Part 1 outlines the reasons for advocacy and the benefits to both patients and doctors, then gives a quick-start outline to get you started. Part 2 will amplify the concepts…

RheumPAC: How the ACR’s Non-Partisan Political Action Committee Works

From the College  |  May 15, 2015

The classic American social studies lesson is How a Bill Becomes a Law, but a more pertinent lesson for U.S. rheumatologists today may be How a Dollar Bill Becomes a PAC. This article is a nuts-and-bolts primer on how exactly RheumPAC works. The purpose is to inform readers about how and why to participate. Money…

HIPAA Security Standards: What Rheumatologists Need to Know

From the College  |  April 1, 2015

Maintain compliance with updated federal rules governing privacy protection for patient health information

Congressional Lawmakers Every Rheumatologist Should Know

From the College  |  April 1, 2015

Key leaders, committee members who can influence federal issues relevant to rheumatology

  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 86
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences